SCHEMBL8286159

SCHEMBL8286159

Cc1cc2c(cn1)c(=O)c(-c1ccccc1)c(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.39
GAA P10253 4/20 0.37
CDK4 P11802 1/20 0.36
CCND1 P24385 1/20 0.36
CCND2 P30279 1/20 0.36
CCND3 P30281 1/20 0.36
MAPK1 P28482 2/20 0.36
HPGD P15428 2/20 0.36
KDM4E B2RXH2 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
ATM Q13315 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TSHR P16473 2/20 0.35
MAT2A P31153 2/20 0.35
CYP1A2 P05177 2/20 0.35
KMT2A Q03164 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 1/20 0.35
USP2 O75604 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8358811 0.91 CYP1A2 (0.43) GAAMAPK1HPGDKDM4ETDP1
SCHEMBL8285356 0.88 GSK3B (0.40) GSK3BGAACDK4CCND1CCND2
SCHEMBL8287541 0.87 GSK3B (0.41) GSK3BGAACDK4CCND1CCND2
SCHEMBL8285354 0.86 GSK3B (0.39) GSK3BGAACDK4CCND1CCND2
SCHEMBL8287492 0.85 GSK3B (0.40) GSK3BGAACDK4CCND1CCND2
SCHEMBL6529785 0.82 SMN1; SMN2 (0.40) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287580 0.82 GSK3B (0.38) GSK3BGAACDK4CCND1CCND2
SCHEMBL8358810 0.80 GSK3B (0.36) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8285349 0.80 GSK3B (0.36) GSK3BGAACDK4CCND1CCND2
SCHEMBL8288002 0.80 GSK3B (0.36) GSK3BGAACDK4CCND1CCND2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed